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Mammalian cellStabilization of cells in a desiccated state can signiﬁcantly simplify the storage and transportation and save
expenses for clinical applications. Introduction of the impermeable disaccharide, trehalose, into cells is an impor-
tant step to improve the desiccation tolerance of cells. In this study, a novel cell penetrating peptide, KRKRWHW,
was developed based on molecular simulations. The peptide exhibited little cytotoxicity and high penetrating
efﬁciency into mammalian cells. The cell viability of mouse embryonic ﬁbroblasts (MEFs) after the incubation
with various concentrations of KRKRWHW from 0.01 mM to 5 mM at 37 °C for 4 h was maintained at around
100%. The peptide was able to penetrate into MEFs within 1 h at 37 °C with an efﬁciency of around 90% at
0.1 mM. Trehalose, as a cargo coupled with the peptide of KRKRWHW through hydrogen bond and π–π bond,
was successfully loaded into the MEFs. This novel peptide provides a novel approach for the delivery of trehalose
into mammalian cells.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Stabilization of cell-based products has become a critical barrier
against their successful commercialization in tissue engineering and
cell therapy etc. [1]. Lyophilization and cryopreservation have been
widely used to stabilize cells and tissues to ensure the off-the-shelf
availability during long-term storage [2]. Due to constraints in the stor-
age and transportation at cryogenic temperature in cryopreservation [3],
storage of cells in the desiccated state would greatly simplify the storage
and transportation and facilitate their applications in clinical therapies.
Trehalose as a non-reducing disaccharide having a high glass transi-
tion temperature and a dihydrate crystalline structure has been demon-
strated to be able to increase the stability of dried liposomes [4], bacteria
[5], yeast and retrovirus [6] and platelets [7]. The stabilization mecha-
nismprovided by trehalose is not fully elaborated. It has been suggested
that trehalose may replace the water shell around macromolecules to
prevent protein aggregation and denaturation [2], depress the phase′,6-diamidino-2-phenylindole;
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4939.transition temperature of membranes to remain membrane integrity
during drying [8,9], and form stable glasses during freeze-drying [10].
Introduction of trehalose into cells is an important step to provide
protection against cell damage during lyophilization [11]. In recent
years numerous approaches have been developed to load trehalose
into mammalian cells to improve desiccation tolerance, including pas-
sive trehalose inﬂux by microinjection [12], genetically engineered
pores [11–13], thermal shock and osmotic shock [14], transient mem-
brane leakage at the phase transition temperature [15], and ﬂuid-phase
endocytosis [16]. The major drawback with these methods is that the
processes of intracellular delivery are not trehalose speciﬁc, which may
further result in the loss of intracellular components through the open
pores. In addition, gene expression biosynthesis of trehalose using a
recombinant adenovirus vector has been applied to introduce trehalose
into human primary ﬁbroblasts [17]. However, this may raise concerns
on the risk during clinical applications. Hence, it is necessary to develop
a novel method to speciﬁcally deliver trehalose into cells without caus-
ing damage to the cells.
Cell penetrating peptides (CPPs), rich in basic amino acids, are short
peptides which can translocate through cell membranes and can be
conjugated with a cargo, such as oligonucleotides [18], plasmids [19],
proteins [20], and enter living cells [21]. The mechanism behind the
translocation is still unclear; presumably endocytosis plays an impor-
tant role in the translocation especially when cargo molecules are
conjugated [22]. Since CPPs can deliver the speciﬁc cargo into the cells
and no intracellular components escape from the cells, CPPs have been
widely used to deliver a variety of cargos into cells without entrapment
in lysosome [23,24]. However, due to the cytotoxicity of CPPs and the
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an alternative CPP offering low cytotoxicity and efﬁcient intracellular
delivery of target molecules needs to be developed.
In this study, a CPP was designed based on the molecular docking
and dynamics simulations and synthesized in order to provide a more
effective and speciﬁc technique for intracellular delivery of trehalose.
The novel CPP is rich in basic amino acid and contains several amino
acids having the ability of coupling with trehalose through non-
covalent bonding. We evaluated the cytotoxicity of the novel CPP and
further examined the efﬁciency of the CPP entering into living MEFs.
The capacity of intracellular trehalose loading using the CPP was also
determined. Our results reveal that the designed CPP exhibits little cyto-
toxicity and a high efﬁciency of intracellular trehalose delivery.
2. Materials and methods
2.1. Materials
Peptide synthesis reagent O-(Benzotriazol-1-yl)-N,N,N′,N′-tetra-
methyluronium tetraﬂuoro-borate (TBTU), N,N-Dimethylformamide
(DMF), 1-Hydroxybenzotriazole (HOBt), N,N-Diisopropylethylamine
(DIEA), isopropanol, triﬂuoroacetic acid (TFA), phenol, thioanisole, 1,2-
eth-anedithiol (EDT), piperidine were purchased from DaTianFengTuo
Chem (Beijing, China). Amino acids andWang resins used in peptide syn-
thesis were purchased from GL Biochem (Shanghai, China). Trehalose
was purchased from Yuanye Bio-Technology (Beijing, China), ﬂuorescein
isothiocyanate (FITC) fromMerck (USA) and dimethyl thiazolyl diphenyl
tetrazolium salt (MTT) from Amresco (USA). Fetal bovine serum (FBS),
trypsin, Dulbecco's Modiﬁed Eagle's medium (DMEM), phosphate buff-
ered saline (PBS), L-glutamine and nonessential amino acid were pur-
chased from Hyclone (USA). Paraformaldehyde and 4′,6-diamidino-2-
phenylindole (DAPI) were purchased from Sigma (USA). Calcein-AM
and propidium iodide (PI) were purchased from Fanbo Biochemicals
(Beijing, China).
2.2. Design of CPPs
The structures of trehalose (TRE) and heparin sulfate (1HPN) were
downloaded from the RCSB protein data bank (PDB). The structure of
polypeptides utilized in the molecular simulations was sketched using
the Discovery Studio Visualizer (DSV) 3.0. Topology and parameters of
force ﬁeld for the trehalose and heparin sulfate were generated using
the PRODRG2 server (http://davapc1.bioch.dundee.ac.uk/cgi-bin/
prodrg_beta) [25]. Molecular docking using the AutoDock 4.0 with
Lamarckian Genetic Algorithm (LGA) was carried out to investigate
the interactions between the designed peptides and trehalose and hep-
arin sulfate. Except for a maximum number of 2,500,000 energy evalu-
ations and 100 runs in 60 × 60 × 60 grid box with spacing at 0.375 Å, all
the other parameters were set as the default.
Molecular dynamics (MD) simulations were carried out using the
GROMACS 4.5.4 and the standard GROMOS96 force ﬁeld. Long-range
electrostatics interactions were treated by the Particle Mesh Ewald
(PME) [26]. The peptide was ﬁrst immersed in a box containing the
Simple Point Charge (Extended) water model, and then the trehalose
and heparin were subsequently added into the system. Each system
for the simulations was neutralized by adding Na+ or Cl−. Before
each system was equilibrated for 20 ps, an energy minimization
was employed. For each system, the simulation was performed at
300 K, physiological pH and 1 atm for a total of 10 ns to assess the sta-
bility of the tested systems. The system stability was veriﬁed by analyz-
ing the energy components and the root mean square deviation
(RMSD) of the structures in the trajectory compared to the starting
conformation. The simulation results were visualized using the Visual
Molecular Dynamics (VMD) and DSV. All computing was performed
on the Lenovo ThinkStation E30 (Lenovo, China).2.3. Synthesis of CPPs
Peptideswere synthesizedmanually on aWang resin using the stan-
dard Fmoc solid-phase synthesis strategy [27]. Fmoc was removed by
DMF containing 20% (v/v) piperidine for up to 30 min, followed by
three washes in isopropanol and DMF at room temperature, respective-
ly. Stepwise coupling of Fmoc-amino acids to the growing peptide chain
on the resin was performed in the reactionmixture of TBTU 0.91 g, DMF
10 ml, HOBt 0.45 g and 0.52 ml DIEA at room temperature for 2 h. After
each amino acid was added, the step of deprotection of Fmoc groupwas
performed. After the last amino acidwas added to the peptide chain, the
cleavage of peptide from the resinwas carried out in themixture of TFA,
triisopropylsilane (TIS), H2O and EDT (94:1:2.5:2.5, v/v) at 0 °C ice-
water while being stirred at 3000 rpm. All crude peptides were puriﬁed
using a reverse-phase high performance liquid chromatography (RP-
HPLC, LC-8A, SHIMADZU, Japan) on a C18 column to purity N95%. The
identity of the puriﬁed peptides was determined using a MALDI-TOF
mass spectrometer (Autoﬂex III LRF200-CID, Bruker, Germany). To visu-
alize the penetration of CPPs, the C-terminal of the CPP was conjugated
with FITC, a ﬂuorescence tag, at the R group of Lys when synthesized.
2.4. Cell culture
MEF cells were cultured and maintained in complete culture medi-
um, DMEM supplemented with 10% FBS, 1% nonessential amino acids
and 1% L-glutamine. All cells were incubated in a 5% CO2 humidiﬁed
atmosphere at 37 °C.
2.5. Cytotoxicity and cell viability assays
Cytotoxicity was assessed using the MTT assay. The MEF cells were
seeded at 8000 cells/well in 96-well plates and cultured for 24 h before
treatment. The cells were incubated in the serum-free culture medium
with various concentrations of peptides in the range from 0.01 mM to
5mM for 4 h in a 5% CO2 humidiﬁed atmosphere at 37 °C. To investigate
the effect of trehalose loaded by the designed CPPs on the cell metabolic
rate, the cells were incubatedwith the CPP and trehalose together for 2 h
in a 5% CO2 humidiﬁed atmosphere at 37 °C. The concentration of the
CPP was 1 mM, and the ratio of the CPP to trehalose was set at 1:8. The
cytotoxicity was determined immediately after the incubation and
after subsequent 24 h of culture by the MTT assay. For the MTT
assay, MTT was added to the tested wells at the ﬁnal concentration
of 1 mg/ml and incubated for 4 h at 37 °C and then 100 μl of DMSO
was added to thewells after themediumwas removed. The absorbance
was determined using a microplate reader (Inﬁnite F20, Tecan,
Switzerland) at 490 nm. The cells cultured with the normal medium
were used as the negative control.
Cell viability of adherent MEFs before and after the incubation with
the CPP was evaluated using the Calcein-AM and PI staining method.
Brieﬂy, the cells were seeded at the density of 4 × 104 cells/well onto
15 mm of coverslips in 24-well plates and incubated with the medium
containing the CPP only or the CPP together with trehalose for 24 h.
The cells immediately after the incubation with the CPP or the CPP
together with trehalose and after subsequent 24 h culture with normal
mediumwere stainedwith 1 μMCalcein-AM and 2 μMPI for 10–15min
in the dark, and then washed with PBS for three times. The green and
red ﬂuorescence in the stained cells were visualized using a ﬂuores-
cencemicroscope (Nikon, Japan) excited at 488nmand 535nm, respec-
tively, connected to an imaging capture system (Tucsen, China). The cell
morphology was visualized using a microscope.
2.6. The cellular uptake assay of CPPs
The MEF cells were seeded onto the coverslips with a diameter of
15mm in 24-well plates at the density of 4 × 104 cells/well and cultured
for 24 h. After the incubation with the serum-free culture medium
Table 1
Docking results for heparin and different peptides containing three to six Arg (kcal/mol).
System Intermolecular energy Torsional free energy Internal energy Binding free energy
VDW-HB
-DESOLVEa
Electrostatic energy
RRR −8.53 −12.27 4.49 −1.47 −13.54
RRRR −8.29 −15.15 6.59 −1.6 −17.2
RRRRR −8.77 −16.89 8.23 −1.33 −16.94
RRRRRR −9.72 −19.29 9.88 0.47 −16.7
a indicates van der Waals, H-bond and desolvation energy.
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0.01, 0.1, 0.2 and 0.5 mM for 1 h in a 5% CO2 humidiﬁed atmosphere
at 37 °C, the cells were washed with PBS, ﬁxed with 4% paraformalde-
hyde, and then stained with DAPI. After three times washing with PBS,
the green ﬂuorescence in the stained cells was visualized using a ﬂuo-
rescence microscope excited at 488 nm connected to an imaging cap-
ture system. The cells show the green ﬂuorescence once the peptides
conjugatedwith FITC are translocated into the cells. To test the penetra-
tion of KW over time, we observed the green ﬂuorescence of cells after
the incubation with KW-FITC at the concentration of 0.2 mM for 5 min
and 20 min using a ﬂuorescence microscope (Nikon, Japan). To deter-
mine the intracellular distribution of this CPP, the cells were incubated
with KW-FITC (0.2 mM) for 30 min and then the green ﬂuorescence
was observed using a confocal microscope (Leica, Germany). To evalu-
ate the uptake efﬁciency, the cells were washed with PBS and digested
using trypsin after the incubation with the FITC-labeled peptides or
FITC-only. The cells were collected, centrifuged and resuspended in
PBS. The ratio of the cells with green ﬂuorescence to the cells without
green ﬂuorescence was taken as the uptake efﬁciency whichwas deter-
mined using a ﬂow cytometer (Cyﬂow Cube6, Partec, Germany). The
cells incubated with the normal culture medium were used as the neg-
ative control.2.7. Intracellular delivery of trehalose
To eliminate interference from the presence of glucose in the culture
medium when measuring the intracellular concentration of trehalose,
the glucose-free culture medium was used here. The designed CPP
(1 mM) was added into the glucose-free culture medium, and then
the trehalose was introduced at the molar ratio of 1:8. The cells were
incubated in the glucose-free culture medium containing both the CPP
and trehalose or trehalose-only for 2 h in a 5% CO2 humidiﬁed atmo-
sphere at 37 °C. After the incubation the cells were washed twice withTable 2
Docking results for heparin and peptides composed of Arg and Lys with various combinations
System Intermolecular energy Tor
VDW-HB
-DESOLVE
Electrostatic energy
RKKK −10.2 −18.2 7.41
KRKR −8.04 −17.98 7.13
RRKK −5.73 −19.89 7.13
RRRR −8.29 −15.15 6.59
KKKK −9.19 −16.3 8.35
KRRK −8.43 −16.38 7.13
RRKR −8.29 −15.17 6.86
KKRK −8.08 −16.98 7.41
KRKK −7.44 −15.59 7.41
RKRK −9.15 −14.87 7.13
RRRK −6.79 −14.69 6.86
KRRR −7.25 −15.67 6.86
KKKR −6.97 −17.15 7.41
KKRR −6.25 −16.01 7.13
RKKR −8.37 −14.65 7.13
RKRR −7.5 −15.21 6.86PBS and left at 4 °C for 30min to detach the cells from the adherent sur-
face. The cells suspended in PBS were counted using a ﬂow cytometer.
The cells cultured in the glucose-free medium with trehalose-only
were used as the positive control and the cells cultured in the glucose-
free culture medium were used as the negative control. The trehalose
concentration was determined by the anthrone reaction [28]. Brieﬂy,
the cells were lysed by a freeze-thawing method. The cell debris was
removed through a 0.22 μm ﬁlter. For the trehalose quantiﬁcation, the
trehalose solution was mixed with anthrone reagent, boiled for 10 min,
and then allowed to cool. The absorbance at 620 nm was read using a
microplate reader and compared with a standard curve. The trehalose
concentration for a single cell was calculated by the mole of trehalose
to the cell volume. Usually the radius of cells is 7–10 μm, therefore
here we regarded the cells as sphere and calculated the cell volume
using the radius of 7 μm. The cell number was counted using a ﬂow
cytometer.
2.8. Statistical analysis
Unless indicated otherwise, at least three independent experi-
ments were conducted for each tested condition. Data are presented
as means ± standard deviation (sdev) for the experiments. One-way
analysis of variance (ANOVA) was performed to determine statistical
signiﬁcance (p b 0.05).
3. Results and discussion
3.1. CPP design
3.1.1. Residues interacting with heparin
Heparin, a highly sulfated glycosaminoglycan with negative charge,
is amember of the glycosaminoglycan family of carbohydrates and con-
sists of a variably sulfated repeating disaccharide unit with a molecular(kcal/mol).
sional free energy Internal energy Binding free energy
0.01 −19.51
−0.45 −17.85
−0.5 −17.51
−1.6 −17.2
−0.95 −17.14
−0.62 −17.11
−1.69 −16.8
−0.29 −16.45
−1.98 −16.1
−0.71 −16.1
−2.92 −16.06
−1.38 −15.94
−0.76 −15.93
−2.07 −15.69
−1.32 −15.69
−1.03 −15.37
Table 3
Docking results for trehalose and peptides composed of Trp and His with various combinations (kcal/mol).
System Intermolecular energy Torsional free energy Internal energy Binding free energy
VDW-HB
-DESOLVE
Electrostatic energy
WWH −7.4 −0.76 3.58 −2.57 −4.64
WHH −5.15 −0.6 3.29 −3.38 −4.55
HHW −4.18 −0.63 3.29 −4.13 −4.35
WHW −7.12 −0.46 3.58 −1.63 −4
HWW −6.7 −0.62 3.58 −2.54 −3.8
WWW −5.02 −0.42 3.58 −2.23 −3.64
HWH −4.52 −0.4 3.29 −3.29 −3.42
HHH −6.12 −0.76 3.58 −1.84 −3.31
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in heparin are composed of a 2-O-sulfated iduronic acid and 6-O-
sulfated and N-sulfated glucosamine. Since heparin sulfates are present
on the plasmamembrane, in this studyheparinwasused as a receptor of
peptide–trehalose complex for designing CPPs based on the interactions
between heparin and CPPs.
Cationic charges of peptide play a critical role in cell penetration
[30,31], especially the guanidinium group of the arginine (Arg, R) side
chain [32]. Therefore, the sequence of peptides was constructed and the
effect of the number of Arg residues in the peptides on the interactions
between the peptides and heparinwas investigated using theAutoDock.
For the running of AutoDock, an empirical scoring systemwas employedFig. 1.Molecular dynamics simulations for the system of peptide–heparin. (A) Snapshots from
Heparin is indicated in blue, and the peptides of RKKK, KRKR and RRKK in red.base on the binding free energy including the intermolecular energy,
internal energy, torsional free energy and unbound system energy. The
binding free energies and the speciﬁc interaction between CPPs and
heparin could be used as a guideline for the design of new CPPs [33].
As shown in Table 1, as expected, the electrostatic energy was increased
with the number of Arg in the sequence of the designed peptides. How-
ever, the peptide RRRR had the lowest internal energy and binding free
energy than the other polyarginines in molecular docking, indicating
that the peptide RRRR having four residues probably had themost stable
conformation and the strongest interaction between RRRR and heparin.
Hence, the peptide RRRRwas initially selected as the potential ligand for
heparin.a simulation trajectory of peptide–heparin at 10 ns. (B) RMSD during the MD simulations.
Fig. 2.Molecular dynamics simulations for the systemof peptide–trehalose. (A) Snapshots from a simulation trajectory of peptide–trehalose at 10ns. (B) RMSDduring theMDsimulations.
Trehalose is indicated in green, and the peptides of WWH, WHH, HHW and WHW in red.
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cell uptake [34] and that the CPPs rich in Arg are difﬁculty in synthesis
[35]. Therefore, a combination of Arg and Lys groups was simulated to
seek the potential candidates for cell penetration. The docking results
for the system of heparin–peptide were listed in Table 2. Considering
the binding free energy and the electrostatic energy, the peptides of
RKKK, KRKR, RRKKwere chosen as the potential candidates for achieving
the function of cell penetration.Table 4
Total free energy (kJ/mol) in the system of trehalose–peptide–heparin according to the
molecular simulations.
Sequence Total free energy among trehalose,
peptide and heparin
Total free energy between
peptide and trehalose
KRKRWHW −83.0677 −48.89
KRKRWHH −287.55 177.866
RKKKWHW −133.023 −131.463.1.2. Residues interacting with trehalose
Trehalosewas supposed to be delivered intomammalian cells by the
designed CPP via a non-covalent strategy. Since tryptophane (Trp, W)
andhistidine (His, H)with the lowest binding free energy have aromatic
R groups which can easily form hydrogen bond (H-bond) and hydro-
phobic interactions with trehalose [36], Trp and His were selected to
be the potential amino acids composing the designed CPP for coupling
trehalose via the non-covalent strategy. The interactions between pep-
tides and trehalose were evaluated using the AutoDock, as shown in
Table 3. Based on the binding free energy and the energy in combination
of van der Waals, H-bond and desolvation energy, the peptides WWH,
WHH, WHW and HHW were selected to couple trehalose through the
non-covalent bonds.
3.1.3. Molecular dynamics simulations
Anumber of forceﬁelds have been developed inmolecular dynamics
simulation, such as CHARMM, AMBER, GROMOS, OLPLS and COMPASS.
Although each force ﬁeld has its particular strength and weakness on
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reasonable results for a wide range of properties of isolated molecules,
pure liquids and aqueous solutions [38]. The force ﬁeld of GROMOS96
has been employed to simulate the interactions between peptide and
trehalose [39,40], and between peptide and heparin [41,42]. To deter-
mine the conformation and stability of the systems, the molecular
dynamics simulations for the system of peptide–trehalose and treha-
lose–peptide–heparin were performed using the Gromacs in a water
environment at 300 K at 1 atm.
As shown in Fig. 1, the peptides RKKK and KRKR formed steady
interactions with heparin, respectively, after 10 ns of simulation except
for the peptide RRKK based on the ﬂuctuation of RMSD. The results
revealed that RKKK and KRKR could generate steady conformations
with heparin whereas RRKK could not. We further simulated the inter-
actions between the peptides of WWH, WHH and WHW and trehalose
(Fig. 2). All the peptides ofWWH,WHHandWHWformed steady inter-
actions with trehalose after 10 ns of simulation except for the peptide
HHW based on the ﬂuctuation of RMSD and the positive value of the
total free energy in the system of HHW–trehalose (data not shown),
suggesting that the process is not spontaneous at constant pressure
and temperature. Therefore the peptides of RRKK and HHWwere elim-
inated from the candidate list for the further experiments.Fig. 3. The molecular simulations for trehalose–peptide–heparin. (A) The RMSD of the system
including trehalose and peptide. (C) The binding conformation of the system containing trehaloAfter the above screening, six peptides were designed based on the
combinations of the sequences of RKKK and KRKR with the sequences
of WWH, WHH and WHW, respectively, for the further screening.
We ﬁrst evaluated the total free energy for the system of treha-
lose–peptide–heparin. However, only three peptides, KRKRWHW,
KRKRWHH and RKKKWHW, had relatively low total free energy in the
system of trehalose–peptide–heparin (Table 4). As shown in Fig. 3,
therewas little change in the RMSD after 10 ns for all the tested systems
(Fig. 3A), revealing that the tested systems were in the steady status
after 10 ns. These results suggest that they might have great potential
for the interactions with trehalose and heparin. Therefore, these three
peptideswere chosen for the next step of design. However, it was inter-
esting to note that the total free energy between KRKRWHH and treha-
lose was very positively high in the system of trehalose–peptide–
heparin (Table 4), indicating that the interaction between KRKRWHH
and trehalose in the system of trehalose–peptide–heparin is not
favorable.
As shown in Fig. 3B, the trehalosewas initially coupledwithWHWat
the preferred interaction sites in the system of trehalose–RKKKWHW,
then migrated to the middle position of RKKKWHW once the heparin
was added to the system (Fig. 3C). The simulation results revealed
that the trehalose experienced the process of re-distribution along thecontaining trehalose, peptide and heparin. (B) The binding conformation of the system
se, peptide and heparin. Trehalose is indicated in green, peptides in red and heparin in blue.
1917Y. Wei et al. / Biochimica et Biophysica Acta 1838 (2014) 1911–1920peptide once the heparin was introduced into the system. In contrast,
the trehalose still interacted with KRKRWHW at WHW as designed
after the heparin was introduced into the system through the H-bond
and π–π bond but not through the covalent bonding. Hence in this
study, the sequence of KRKRWHW (hereafter referred to as KW) was
ﬁnally selected as the potential CPP for the intracellular delivery of
trehalose.3.2. In vitro cytotoxicity of KW
The cytotoxicity of CPPs depends on the charge, hydrophobicity,
length and structure [43], concentration, cargo molecule and coupling
strategy [44]. To determine the cytotoxicity proﬁle of KW, here the
mammalian cells, mouse embryonic ﬁbroblasts (MEFs), were evaluated
at physiological pH by the MTT assay. The cytotoxicity was evaluated
after 4 h of exposure to the various concentrations of 0.1, 0.5, 1, 2 and
5 mM KW at 37 °C in 5% CO2. As shown in Fig. 4A, after 4 h of exposure
to the culturemediumcontainingKW, the presence of KWdid not cause
a signiﬁcant decrease in the cell viability, even at 5mMof KW, and near-
ly all the cells were viable for all the tested conditions. We further
detected the cytotoxicity after 24 h of culture in the normal culture
medium following 4 h of exposure to the medium containing KW. In
comparison with the control, there was no signiﬁcant change in the
cell viability (Fig. 4B), and nearly all the cells were viable for the tested
conditions (Fig. 4C), indicating that the CPP designed here had no signif-
icant cytotoxicity at physiological pH even at the concentration of 5mM.Fig. 4. The cytotoxic effects of KWon cell viability after incubationwith various concentrations of
incubation with different concentrations of KW. (B) The cell viability after 24 h culture in the no
morphology and cell viability immediately and 24 h after 4 h incubationwith various concentrati
ﬂuorescence microscope. Green: live cells, Red: dead cells. KW is short for the peptide of KRKRWThe negligible cytotoxicity induced by KW may beneﬁt from the short
length of KW and its low cationic charge [30]. The low hydrophobicity
in the domain of KWmay be another contribution for the little cytotox-
icity caused by KW.3.3. Cellular uptake of KW
The structure and cationic content of CPP appear to be responsible
for the cell membrane translocation property [45]. Here KW labeled
with FITC (KW-FITC)was used to evaluate the efﬁciency of the CPP pen-
etration. It has been demonstrated that the N-terminal of a CPP coupled
with ﬂuorescein can lead to the increased membrane destabilization
and elevated cytotoxicity caused by the increase in the hydrophobic
nature of the peptide tail [44]. Therefore, KWwas coupled with ﬂuores-
cein at the C-terminal. The extent of penetration is related to the incuba-
tion temperature and the extracellular concentration [46–48]. The cells
at the seeding density of 4 × 104 cells/well were cultured in the pres-
ence of KW-FITC or FITC-only at the concentrations of 0.01 mM,
0.1 mM, 0.2 mM and 0.5 mM at 37 °C in 5% CO2 for 1 h, respectively.
The cellular uptake of KWwasmonitored using the ﬂuorescencemicro-
scope and the efﬁciency was determined using the ﬂow cytometer. As
shown in Fig. 5A, the green ﬂuorescence was observed for all the tested
concentrations and the intensity was increased with the concentration
of KW-FITC. In addition, the green ﬂuorescence could be obviously
observed even at 5 min and became stronger over time (Fig. 5B). Since
the ﬂuorescence was weak, and was faint for the confocal observationKW in a 5% CO2 humidiﬁed atmosphere at 37 °C. (A) The cell viability immediately after 4 h
rmal culture medium following 4 h exposure of various concentrations of KW. (C) The cell
ons of KW. The cells were stained by Calcein-AM (1 μM) and PI (2 μM) and observed using a
HW. Bar = 200 μm.
Fig. 5. The intracellular uptake of KW labeled with FITC. (A) Visualization of the translocation of various concentrations of KW-FITC. Bar = 200 μm. (B) The intracellular accumulation of
KW-FITC over time and its distribution. Cellswere incubatedwith KW-FITC at the concentration of 0.2mM for 5min and 20min, respectively. The greenﬂuorescencewas observed using a
ﬂuorescence microscope. For the intracellular localization of KW-FITC, the cells were incubated with KW-FITC for 30 min and then the green ﬂuorescence was observed using a confocal
microscope. The cells incubatedwith FITC-onlywere used as the control. (C) The percentage of the cells containingKW-FITC tested by FACS analysis. (D) The representative results of FACS
analysis. FITC-only was used as the controls. KW is short for the peptide of KRKRWHW. The asterisks (**, p b 0.01) indicate the signiﬁcant difference.
1918 Y. Wei et al. / Biochimica et Biophysica Acta 1838 (2014) 1911–1920at 0.001 to 0.01mM, the result at 0.2mMwas presented. In contrast, the
cells incubated with FITC-only did not show any visible green ﬂuores-
cence. These results indicate that the peptide KRKRWHW can efﬁciently
penetrate into cells. To determine the intracellular distribution of this
CPP, the cells were incubated with KW-FITC for 30 min and then the
green ﬂuorescence was observed using the confocal microscope. TheFig. 6. The intracellular concentration of trehalose delivered by KW. The cells normally cul-
tured (Blank) were used as the negative control. KW is short for the peptide of
KRKRWHW. The asterisks (**, p b 0.01) indicate the signiﬁcant difference.result showed that the green ﬂuorescence was observed throughout
the cells (Fig. 5B), implying that the peptideswere located in the plasma
and nuclear.
At the concentration of 0.1 mM, nearly 90% of the cells were FITC
positive (Fig. 5C), even at the concentration of 0.01 mM, around 60%
of MEF cells appeared in green, indicating that the KW efﬁciently
translocated into the cells without causing damages to the cell mem-
branes (Fig. 4C). Usually the length required for an efﬁcient arginine-
rich CPP is greater than 8 amino acids. It is quite surprised that the
CPP designed here, shorter than most CPPs, efﬁciently penetrated into
mammalian cells, even within 5 min at the concentration of 0.2 mM
as shown in Fig. 5B. With the help of the CPP, the FITC conjugated
with the CPP was successfully translocated into the cells. In contrast,
the FITC only did not penetrate into the cells. This indicates that the
CPP described here has the capacity of penetration. The mechanism
for the efﬁcient penetration of KW needs to be elucidated further.
To avoid the false positive results caused by the cell membrane sur-
face bound FITC, cells are usually treated with trypsin [22]. After diges-
tion, the ﬂuorescence activated cell sorting (FACS) results revealed that
although there was a slight ﬂuorescence signal generated by the FITC
bound to the cell membranes, theﬂuorescence signal thatwas observed
in the presence of KW-FITC was much stronger, indicating that the
1919Y. Wei et al. / Biochimica et Biophysica Acta 1838 (2014) 1911–1920peptides of KW were translocated and accumulated inside the cells
(Fig. 5A and D). However, the surface bound FITC could not be com-
pletely removed by the trypsin digestion, hence a threshold for the ﬂuo-
rescence test was adjusted for each condition in comparison with the
cells cultured with FITC-only medium (Fig. 5D). It should be noticed
that this could have resulted in an underestimation of the uptake
efﬁciency due to an overestimation of the number of the surface
bound FITC.
3.4. Intracellular delivery of trehalose
The CPP is able to carry a diversity of molecules ranging from small
molecules of some hundreds of Daltons to massive structures with a
diameter up to 200 nm [49,50]. It is important to use appropriate CPPs
for desired cargos since no single CPP is effective in delivery for all bio-
activemolecules [20,49]. The KWwas designed to deliver trehalose into
mammalian cells. During the simulations, the ratio of trehalose to KW
was set at 1:1. When eight trehalose molecules were introduced into
the simulation system, we found these trehalose grouped together
though the H-bond and bound to the heparin (data not shown).
Therefore, to evaluate the capacity of the trehalose loading, the treha-
lose (8 mM) with KW (1 mM) was loaded to the adherent MEF cells
at physiological pH at 37 °C in 5% CO2 for 2 h. Fig. 6 shows the intracel-
lular trehalose concentration after 2 h incubation for all the tested con-
ditions. In comparison with the cells incubated with trehalose only,
there was a signiﬁcant increase in the intracellular trehalose concentra-
tionwhen the KW and trehalose were both loaded. This implicated thatFig. 7. The cytotoxicity of trehalose loaded by KW. (A) The cell viability after the incubationwith
PI (2 μM) staining by a ﬂuorescencemicroscope. The cell viability andmorphologywere determ
of KRKRWHW. Green: living cells. Red: dead cells. Bar = 200 μm.the uptake of trehalosewasmainlymediated by the CPP. A further study
is needed to elucidate themechanism behind the intracellular trehalose
delivery with the help of KW.
To determine the intracellular concentration of trehalose, the cells
must be lysed to release trehalose. Here, the freeze-thawing method
was used to disrupt the cell membranes to release trehalose, which
may lead to an underestimation of the intracellular trehalose concentra-
tion. In addition, the intracellular trehalose concentration may also be
underestimated approximately by a factor of two due to not taking
account of the osmotically inactive volume which is 56% of the isotonic
cell volume [51].
Furthermore, dialysis was performed to determine the interactions
betweenKWand trehalose, which conﬁrmed that KWcould bind treha-
lose (Supplementary content). The further experiments are needed to
determine the loading limit of trehalose with the help of KW.
3.5. Cytotoxicity after KW translocation with trehalose
The cargo and the cargo-coupling position within the peptide also
affect the cytotoxicity of the peptide [44].We further tested the cytotox-
icity after the trehalose was delivered into the cells using the designed
CPP. The cytotoxicitywas determined immediately and 24 h after treha-
lose loading. In comparison with the control, the trehalose loaded using
the KW did not result in a loss in the cell viability, and the cells main-
tained their metabolic state and morphology (Fig. 7), suggesting that
KW has the capacity of translocating trehalose into mammalian cells
without causing cell death.KWand trehalose. (B) The cell morphology in (A) visualized after Calcein-AM (1 μM) and
ined immediately and 24 h after 4 h incubationwith 1mMKW. KW is short for the peptide
1920 Y. Wei et al. / Biochimica et Biophysica Acta 1838 (2014) 1911–19204. Conclusions
A novel cell penetrating peptide, KRKRWHW, was developed to
deliver non-cell permeable trehalose into mammalian cells based on
themolecular simulations. The CPP is able to efﬁciently deliver trehalose
intomammalian cellswith little cytotoxicity tomammalian cells even at
high concentration. Therefore, this CPP may be very helpful for improv-
ing the desiccation tolerance of cells. The development of this CPP pro-
vides a novel approach for the delivery of trehalose into mammalian
cells.
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